These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29635469)

  • 21. Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts.
    Kawakami Y; Matsuda T; Hidaka N; Tanaka M; Kimura E
    J Am Med Inform Assoc; 2024 Jun; 31(7):1561-1568. PubMed ID: 38758661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for managing variation in clinical drug names.
    Peters L; Kapusnik-Uner JE; Bodenreider O
    AMIA Annu Symp Proc; 2010 Nov; 2010():637-41. PubMed ID: 21347056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation and enhancement of a computable medication indication resource (MEDI) using a large practice-based dataset.
    Wei WQ; Mosley JD; Bastarache L; Denny JC
    AMIA Annu Symp Proc; 2013; 2013():1448-56. PubMed ID: 24551419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracting drug indication information from structured product labels using natural language processing.
    Fung KW; Jao CS; Demner-Fushman D
    J Am Med Inform Assoc; 2013 May; 20(3):482-8. PubMed ID: 23475786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Summary and analysis of safety warning on clinical application of anti-cold Chinese patent medicine preparations].
    Lai XX; Lin H; Luo YN; Wang YY; Duan XH; Wang L; Luo R; Chen YH
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1594-600. PubMed ID: 26281605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardized drug and pharmacological class network construction.
    Zhu Q; Jiang G; Wang L; Chute CG
    Stud Health Technol Inform; 2013; 192():1125. PubMed ID: 23920899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enabling Hierarchical View of RxNorm with NDF-RT Drug Classes.
    Palchuk MB; Klumpenaar M; Jatkar T; Zottola RJ; Adams WG; Abend AH
    AMIA Annu Symp Proc; 2010 Nov; 2010():577-81. PubMed ID: 21347044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enabling complex queries to drug information sources through functional composition.
    Peters L; Mortensen J; Nguyen T; Bodenreider O
    Stud Health Technol Inform; 2013; 192():692-6. PubMed ID: 23920645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes].
    Ma LX; Wang YY; Li XX; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2012 Mar; 10(3):279-92. PubMed ID: 22409917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A High-Fidelity Combined ATC-Rxnorm Drug Hierarchy for Large-Scale Observational Research.
    Ostropolets A; Talapova P; De Wilde M; Abedtash H; Rijnbeek P; Reich CG
    Stud Health Technol Inform; 2024 Jan; 310():53-57. PubMed ID: 38269764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital pharmacy practice in the People's Republic of China.
    Liu GJ
    Am J Hosp Pharm; 1982 Sep; 39(9):1487-90. PubMed ID: 7137184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application characteristics and situation analysis of volatile oils in database of Chinese patent medicine].
    Wang SJ; Wu ZF; Yang M; Wang YQ; Hu PY; Jie XL; Han F; Wang F
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3379-83. PubMed ID: 25522633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of RxNorm for Medication Clinical Decision Support.
    Freimuth RR; Wix K; Zhu Q; Siska M; Chute CG
    AMIA Annu Symp Proc; 2014; 2014():554-63. PubMed ID: 25954360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm.
    Peters LB; Bodenreider O
    AMIA Annu Symp Proc; 2015; 2015():1034-41. PubMed ID: 26958241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research on evaluation criteria over quality as core index of high grade Chinese patent medicine].
    Liu Y; Yu HC; Zhang J; Chen C; Cheng JT; Song ZH; Liu A
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4356-4360. PubMed ID: 30583641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions.
    Lester CA; Flynn AJ; Marshall VD; Rochowiak S; Rowell B; Bagian JP
    J Am Med Inform Assoc; 2022 Aug; 29(9):1471-1479. PubMed ID: 35773948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on regional distribution characteristics and changing trend of Chinese patent medicine industry].
    Wang H; Zhang XB; Zhao YP; Shi TT; Yang G
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2814-2819. PubMed ID: 29098843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis.
    Hua Z; Zhai FT; Tian J; Gao CF; Xu P; Zhang F; Liu SJ; Dong K; Du XF; Zhang Z; Yang G
    BMJ Open; 2019 Sep; 9(9):e026136. PubMed ID: 31542734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using RxNorm for cross-institutional formulary data normalization within a distributed grid-computing environment.
    Wynden R; Anderson N; Casale M; Lakshminarayanan P; Anderson K; Prosser J; Errecart L; Livshits A; Thimman T; Weiner M
    AMIA Annu Symp Proc; 2011; 2011():1559-63. PubMed ID: 22195221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.